Skip to content

Clinical trials

Withdrawn Breast Carcinoma In Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20101
20111
20182
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ETOP IBCSG Partners Foundation1
Fox Chase Cancer Center1
Fred Hutchinson Cancer Center1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Mark Dewhirst1
Mayo Clinic1
Northwestern University1
Ohio State University Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ8
Breast Neoplasms6
Carcinoma, Intraductal, Noninfiltrating6
Carcinoma, Lobular1
Cicatrix1
Dyspareunia1
Fibroadenoma1
Osteoporosis1
Phyllodes Tumor1

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.